Abstract
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver injury. The spectrum of NAFLD is broad, extending from simple steatosis through nonalcoholic steatohepatitis (NASH). Iron is regarded as a putative element that interacts with oxygen radicals, and high rates of hyperferritinemia and increased hepatic iron stores have been demonstrated in NASH. We investigated serum ferritin concentrations, HFE gene mutations, and insulin resistance in Japanese NASH patients and the diagnostic utility of serum ferritin concentrations as a means of distinguishing NASH. Serum ferritin concentrations were measured in 86 patients with histopathologically verified NAFLD (24 with steatosis and 62 with NASH) and 20 control subjects, they were tested for HFE gene mutations and their insulin resistance was measured. The serum ferritin concentration was significantly higher in the NASH patients than in the patients with simple steatosis (P = 0.006). There was no significant difference between the groups in HFE gene mutation (C282Y, H63D, and S65C), and the serum ferritin level was related with insulin resistance. The area under the ROC curve was 0.732 for distinguishing NASH from simple steatosis (P = 0.005; 95% CI, 0.596–0.856). In conclusion high serum ferritin concentrations are a distinguishing feature of Japanese NASH patients independent of HFE gene mutations.
Similar content being viewed by others
Abbreviations
- NASH:
-
Nonalcoholic steatohepatitis
- NAFLD:
-
Nonalcoholic fatty liver disease
- IR:
-
Insulin resistance
- PCR:
-
Polymerase chain reaction
- VFA:
-
Visceral fat area
- BMI:
-
Body mass index
- SFA:
-
Subcutaneous fat area
- HOMA-IR:
-
Homeostasis model assessment for insulin resistance
References
Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;18:1221–1231. doi:10.1056/NEJMra011775.
Farrell GC. Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region? J Gastroenterol Hepatol. 2003;18:124–138. doi:10.1046/j.1440-1746.2003.02989.x.
Diehl AM, Goodman Z, Ishak KG. Alcohol-like liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology. 1998;95:1056–1062.
Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980;55:434–438.
Yoneda M, Mawatari H, Fujita K, et al. Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage. J Gastroenterol. 2007;42:375–381. doi:10.1007/s00535-007-2014-3.
Yoneda M, Mawatari H, Fujita K, et al. High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. J Gastroenterol. 2007;42:573–582. doi:10.1007/s00535-007-2060-x.
Yoneda M, Uchiyama T, Kato S, et al. Plasma Pentraxin3 is a novel marker for nonalcoholic steatohepatitis (NASH). BMC Gastroenterol. 2008;8:53. doi:10.1186/1471-230X-8-53.
Yoneda M, Yoneda M, Fujita K, et al. Transient elastography in patients with nonalcoholic fatty liver disease (NAFLD). Gut. 2007;56:1330–1331. doi:10.1136/gut.2007.126417.
Yoneda M, Yoneda M, Mawatari H, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis. 2008;40:371–378. doi:10.1016/j.dld.2007.10.019.
Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123:745–750. doi:10.1053/gast.2002.35354.
Day CP, James OF. Steatohepatitis: a tale of two “hit”? Gastroenterology. 1998;114:842–845. doi:10.1016/S0016-5085(98)70599-2.
George DK, Goldwurm S, MacDonald GA, et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology. 1998;114:311–318. doi:10.1016/S0016-5085(98)70482-2.
James OF, Day CP. Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J Hepatol. 1998;29:495–501. doi:10.1016/S0168-8278(98)80073-1.
Bonkovsky HL, Jawaid Q, Tortorelli K, et al. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. J Hepatol. 1999;31:421–429. doi:10.1016/S0168-8278(99)80032-4.
Mendler MH, Turlin B, Moirand R, et al. Insulin resistance-associated hepatic iron overload. Gastroenterology. 1999;117:1155–1163. doi:10.1016/S0016-5085(99)70401-4.
Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419. doi:10.1007/BF00280883.
Yoshizumi T, Nakamura T, Yamane M, et al. Abdominal fat: standardized technique for measurement at CT. Radiology. 1999;211:283–286.
Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002;21:27–41.
Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis. 2001;21:3–16. doi:10.1055/s-2001-12925.
Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399–408. doi:10.1038/ng0896-399.
Kazemi-Shirazi L, Datz C, Maier-Dobersberger T, et al. The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C. Gastroenterology. 1999;116:127–134. doi:10.1016/S0016-5085(99)70236-2.
Adams PC, Chakrabarti S. Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria. Gastroenterology. 1998;114:319–323. doi:10.1016/S0016-5085(98)70483-4.
Hayashi H, Takikawa T, Nishimura N, et al. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. Am J Gastroenterol. 1994;89:986–988.
Sumida Y, Kanemasa K, Fukumoto K, et al. Effect of iron reduction by phlebotomy in Japanese patients with nonalcoholic steatohepatitis: a pilot study. Hepatol Res. 2006;36:315–321. doi:10.1016/j.hepres.2006.08.003.
Videla LA, Fernández V, Tapia G, et al. Oxidative stress-mediated hepatotoxicity of iron and copper: role of Kupffer cells. Biometals. 2003;16:103–111. doi:10.1023/A:1020707811707.
Houglum K, Filip M, Witztum JL, et al. Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload. J Clin Invest. 1990;86:1991–1998. doi:10.1172/JCI114934.
Kadiiska MB, Burkitt MJ, Xiang QH, et al. Iron supplementation generates hydroxyl radical in vivo. An ESR spin-trapping investigation. J Clin Invest. 1995;96:1653–1657.
Pietrangelo A. Iron, oxidative stress and liver fibrogenesis. J Hepatol. 1998;28(suppl 1):8–13. doi:10.1016/S0168-8278(98)80368-1.
Lustbader ED, Hann HW, Blumberg BS. Serum ferritin as a predictor of host response to hepatitis B virus infection. Science. 1983;220:423–425. doi:10.1126/science.6301008.
Jazwinska EC, Cullen LM, Busfield F, et al. Haemochromatosis and HLA-H. Nat Genet. 1996;14:249–251. doi:10.1038/ng1196-249.
Douabin V, Deugnier Y, Jouanolle AM, et al. Polymorphisms in the haemochromatosis gene. International Symposium on iron in biology and medicine. Saint-Malo, France, 1997, p 267.
Chitturi S, Weltman M, Farrell GC, et al. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity. Hepatology. 2002;36:142–149. doi:10.1053/jhep.2002.33892.
Deguti MM, Sipahi AM, Gayotto LC, et al. Lack of evidence for the pathogenic role of iron and HFE gene mutations in Brazilian patients with nonalcoholic steatohepatitis. Braz J Med Biol Res. 2003;36:739–745. doi:10.1590/S0100-879X2003000600009.
Duseja A, Das R, Nanda M, et al. Nonalcoholic steatohepatitis in Asian Indians is neither associated with iron overload nor with HFE gene mutations. World J Gastroenterol. 2005;11:393–395.
Yamauchi N, Itoh Y, Tanaka Y, et al. Clinical characteristics and prevalence of GB virus C, SEN virus, and HFE gene mutation in Japanese patients with nonalcoholic steatohepatitis. J Gastroenterol. 2004;39:654–660. doi:10.1007/s00535-003-1361-y.
Sohda T, Yanai J, Soejima H, et al. Frequencies in the Japanese population of HFE gene mutations. Biochem Genet. 1999;37:63–68. doi:10.1023/A:1018718101579.
Dobbins RL, Szczepaniak LS, Myhill J, et al. The composition of dietary fat directly influences glucose-stimulated insulin secretion in rats. Diabetes. 2002;51:1825–1833. doi:10.2337/diabetes.51.6.1825.
Dongiovanni P, Valenti L, Ludovica Fracanzani A, et al. Iron depletion by deferoxamine up-regulates glucose uptake and insulin signaling in hepatoma cells and in rat liver. Am J Pathol. 2008;172:738–747. doi:10.2353/ajpath.2008.070097.
Valenti L, Fracanzani AL, Dongiovanni P, et al. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study. Am J Gastroenterol. 2007;102:1251–1258. doi:10.1111/j.1572-0241.2007.01192.x.
Chitturi S, Abeygunasekera S, Farrell GC, et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology. 2002;35:373–379. doi:10.1053/jhep.2002.30692.
Acknowledgments
We thank Miss Machiko Hiraga for her technical support. This work was supported in part by a Grant-in-Aid from the Ministry of Health, Labour and Welfare of Japan to A.N., a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (KIBAN-B) to A.N., and a grant from the National Institute of Biomedical Innovation to A.N.
Author information
Authors and Affiliations
Corresponding author
Additional information
Masato Yoneda and Yuichi Nozaki contributed equally to this work.
Rights and permissions
About this article
Cite this article
Yoneda, M., Nozaki, Y., Endo, H. et al. Serum Ferritin Is a Clinical Biomarker in Japanese Patients with Nonalcoholic Steatohepatitis (NASH) Independent of HFE Gene Mutation. Dig Dis Sci 55, 808–814 (2010). https://doi.org/10.1007/s10620-009-0771-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-009-0771-y